Epilepsy and suicide: pathogenesis, risk factors, and prevention.

Neuropsychiatric Disease and Treatment
Alberto VerrottiFilippo Maria Ferro

Abstract

Depression and suicide tendencies are common in chronic diseases, especially in epilepsy and diabetes. Suicide is one of the most important causes of death, and is usually underestimated. We have analyzed several studies that compare mortality as a result of suicide in epileptic patients and in the general population. All the studies show that epileptic patients have a stronger tendency toward suicide than healthy controls. Moreover it seems that some kinds of epilepsy have a higher risk for suicide (temporal-lobe epilepsy). Among the risk factors are surgery therapy (suicide tendency five times higher than patients in pharmacological therapy), absence of seizures for a long time, especially after being very frequent, and psychiatric comorbidity (major depression, anxiety-depression disorders, personality disorders, substance abuse, psychoses). The aim of the review was to analyze the relationship between suicide and epilepsy, to identify the major risk factors, and to analyze effective treatment options.

References

Nov 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·G D ShuklaP K Mohan
Jan 1, 1992·International Journal of Psychiatry in Medicine·M F Mendez, R C Doss
Jul 1, 1987·Epilepsia·M M RobertsonH R Townsend
Aug 1, 1986·Archives of Neurology·M F MendezD F Benson
Jan 1, 1994·British Journal of Pharmacology·A AlemayehuC C Chou
Jun 1, 1994·Postgraduate Medical Journal·J O Obafunwa, A Busuttil
Oct 1, 1993·The British Journal of Psychiatry : the Journal of Mental Science·E FiordelliV Crespi
Jul 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·R ManchandaP A Derry
Aug 1, 1996·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·J C SurísC Puig
Dec 28, 1999·Epilepsia·M V Lambert, M M Robertson
Mar 25, 2000·The Journal of Clinical Psychiatry·D BlumerA R Wyler
Apr 24, 2002·Neurology·Andres M Kanner, Antoaneta Balabanov
Jun 13, 2002·Epilepsia·Lena NilssonTorbjörn Tomson
Aug 30, 2002·The New England Journal of Medicine·David A Brent, Boris Birmaher
Oct 26, 2002·Epilepsy Research·Toshihiko FukuchiTeiichi Onuma
Apr 12, 2003·Epilepsia·Derek OttRochelle Caplan
Nov 1, 2003·Epilepsy & Behavior : E&B·Jana E JonesKimford J Meador
Nov 1, 2003·Epilepsy & Behavior : E&B·Sigita Plioplys
Jan 17, 2004·Epilepsy & Behavior : E&B·Rianne ReijsMarc De Krom
Jan 28, 2004·Neurologic Clinics·Ann M Lagges, David W Dunn
Mar 5, 2005·The Journal of Neuropsychiatry and Clinical Neurosciences·Christian Prueter, Christine Norra
Apr 12, 2005·Epilepsy & Behavior : E&B·Vladimir V Kalinin, Dmitriy A Polyanskiy
Apr 29, 2005·Epilepsia·Rochelle CaplanW Donald Shields
Jul 6, 2005·Epilepsy & Behavior : E&B·Maurizio PompiliRoberto Tatarelli
Oct 4, 2005·Epilepsy & Behavior : E&B·Vladimir V Kalinin, Dmitriy A Polyanskiy
Mar 29, 2006·Neurology·Gus A Baker
Oct 3, 2006·Epilepsy & Behavior : E&B·Maurizio PompiliRoberto Tatarelli

❮ Previous
Next ❯

Citations

Dec 16, 2010·Epilepsy Currents·Dale C HesdorfferAndres M Kanner
May 31, 2011·Expert Opinion on Drug Safety·Sherifa Ahmad Hamed
Sep 13, 2015·Seizure : the Journal of the British Epilepsy Association·Amina ChentoufStylianos E Antonarakis
Mar 11, 2016·Epilepsy & Behavior : E&B·Dylan P ThibaultAllison W Willis
Jun 19, 2013·General Hospital Psychiatry·Folorunsho Tajudeen NuhuSa'ad Bolakale Aremu
Feb 27, 2013·Journal of Psychosomatic Research·Milena GandyArmin Mohamed
Mar 19, 2014·Cognitive Behaviour Therapy·Milena GandyArmin Mohamed
May 28, 2014·Arquivos de neuro-psiquiatria·Cristina Maria Duarte WiggMarleide da Mota Gomes
Jul 14, 2011·Nature Reviews. Neurology·Christian Hoppe, Christian E Elger
Jul 20, 2018·Journal of Neuroscience Research·Tore EidHitten P Zaveri
Jul 8, 2010·Journal of Clinical Neurology·Hye-Won LimSoon-Hak Kwon
Jan 30, 2015·Journal of Clinical Neurology·Jong-Geun SeoSung-Pa Park
Jan 22, 2011·Harvard Review of Psychiatry·Lior GivonPieter A Cohen
Jun 18, 2009·Current Opinion in Neurology·Gail S Bell, Josemir W Sander
Apr 27, 2019·International Journal of Environmental Research and Public Health·Nicholas AbrahamRoger C Ho
Jan 1, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·M S ZinchukA B Guekht
Sep 17, 2021·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Mariacarolina VaccaClaudio Liguori

❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.